Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: A pediatric oncology group study

Journal of Clinical Oncology

Volumn 24, Issue 19, 2006, Pages 3142-3149

  Barredo, Julio C ^a   Devidas, Meenakshi ^b   Lauer, Stephen J ^b   Billett, Amy ^b   Marymont, MaryAnne ^b   Pullen, Jeanette ^b   Camitta, Bruce ^b   Winick, Naomi ^b   Carroll, William ^b   Ritchey, A Kim ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; THIOTEPA; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SINGLE DRUG DOSE; THROMBOCYTOPENIA; TREATMENT RESPONSE; ACUTE LYMPHOCYTIC LEUKEMIA; BRAIN TUMOR; CLINICAL TRIAL; DRUG ADMINISTRATION; INFANT; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; SKULL IRRADIATION; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33746012670     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.3373     Document Type: Article

References (36)

1. Ritchey AK, Pollock BH, Lauer SJ, et al: Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: A pediatric oncology group study. J Clin Oncol 17:3745-3752, 1999
2. Silverman LB, Declerck I, Gelber RD, et al: Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 14: 2247-2256, 2000
3. Winick NJ, Smith SD, Shuster J, et al: Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 11:271-278, 1993
4. Henze G, Fengler R, Hartmann R, et al: Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85): A relapse study of the BFM group. Blood 78:1166-1172, 1991
5. Mandell LR, Steinherz P, Fuks Z: Delayed central nervous system (CNS) radiation in childhood CNS acute lymphoblastic leukemia: Results of a pilot trial. Cancer 66:447-450, 1990
6. Gaynon PS, Trigg ME, Heerema NA, et al: Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 14: 2223-2233, 2000
7. Shay H, Zarafonetis C, Smith N, et al: Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA): Preliminary results in experimental and clinical leukemia. AMA Arch Intern Med 92:628-645, 1953
8. Bundles RW, Barton WB: Triethylene melamine in the treatment of neoplastic disease. Blood 7:483-507, 1952
9. Gutin PH, Weiss HD, Wiernik PH, et al: Intrathecal N, N′, N′-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant meningeal disease: Phase I-II study. Cancer 38: 1471-1475, 1976
10. Heideman RL, Cole DE, Balis F, et al: Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: Evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 49:736-741, 1989
11. Mahoney DH Jr, Shuster J, Nitschke R, et al: Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group phase III trial. J Clin Oncol 16:246-254, 1998
12. Pullen J, Boyett J, Shuster J, et al: Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 11: 839-849, 1993
13. Lauer SJ, Shuster JJ, Mahoney DH Jr, et al: A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group phase III randomized trial. Leukemia 15:1038-1045, 2001
14. Asselin B, Shuster J, Amylon M, et al: Improved event-free survival (EFS) with high dose methotrexate 9HDM) in T-cell lymphoblastic leuekmia 9T-ALL) and advanced lymphoblastic lymphoma (T-NHL): A Pediatric Oncology Group (POG) study. Proc Soc Clin Oncol 20:367a, 2001 (abstr 1464)
15. Gelber RD, Sallan SE, Cohen HJ, et al: Central nervous system treatment in childhood acute lymphoblastic leukemia: Long-term follow-up of patients diagnosed between 1973 and 1985. Cancer 72:261-270, 1993
16. Land VJ, Thomas PR, Boyett JM, et al: Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia: A Pediatric Oncology Group study. Cancer 56:81-87, 1985
17. Ribeiro RC, Rivera GK, Hudson M, et al: An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 13:333-338, 1995
18. Neale GA, Pui CH, Mahmoud HH, et al: Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia. Leukemia 8:768-775, 1994
19. Goulden N, Langlands K, Steward C, et al: PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia, Br J Haematol 87: 282-285, 1994
20. O'Reilly J, Meyer B, Baker D, et al: Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia. Leukemia 9:624-627, 1995
21. Bleyer WA: The impact of childhood cancer on the United States and the world. CA Cancer J Clin 40:355-367, 1990
22. Kieffer-Renaux V, Bulteau C, Grill J, et al: Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Dev Med Child Neurol 42:741-745, 2000
23. Gajjar A, Mulhern RK, Heideman RL, et al: Medulloblastoma in very young children: Outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 12: 1212-1216, 1994
24. Steen RG, Spence D, Wu S, et al: Effect of therapeutic ionizing radiation on the human brain. Ann Neurol 50:787-795, 2001
25. Waber DP, Tarbell NJ, Fairclough D, et al: Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: Cranial radiation requires an accomplice. J Clin Oncol 13:2490-2496. 1995
26. Brown RT, Madan-Swain A, Walco GA, et al: Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol 23:333-340, 1998
27. Appleton RE, Farrell K, Zaide J, et al: Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukaemia. Arch Dis Child 65:530-534, 1990
28. Jankovic M, Brouwers P, Valsecchi MG, et al: Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia: ISPACC - International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 344:224-227, 1994
29. Pui CH, Cheng C, Leung W, et al: Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349:640-649, 2003
30. Leung W, Hudson M, Zhu Y, et al: Late effects in survivors of infant leukemia. Leukemia 14:1185-1190, 2000
31. Relander T, Cavallin-Stahl E, Garwicz S, et al: Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 35:52-63, 2000
32. Probert JC, Parker BR: The effects of radiation therapy on bone growth. Radiology 114:155-162, 1975
33. Egorin MJ, Snyder SW: Characterization of nonexchangeable radioactivity in L1210 cells incubated with [14C]thiotepa: Labeling of phosphatidylethanolamine. Cancer Res 50:4044-4049, 1990
34. Miller B, Tenenholz T, Egorin MJ, et al: Cellular pharmacology of N,N′,N″-triethylene thiophosphoramide. Cancer Lett 41:157-168, 1988
35. Messina C, Cesaro S, Rondelli R, et al: Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/ FONOP-TMO Group: Italian Association of Paediatric Haemato-Oncology. Bone Marrow Transplant 21:1015-1021, 1998
36. Nagatoshi Y, Kawano Y, Nagayama J, et al: Treatment of isolated central nervous system relapse in high-risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy. Br J Haematol 125:766-768, 2004